GLPwatch

Byetta vs Victoza

Drug comparison

Last updated 2026-05-28 15:46 UTC

Byetta (exenatide by AstraZeneca) and Victoza (liraglutide by Novo Nordisk) are both injectable medications for type 2 diabetes, but Victoza is also approved to reduce cardiovascular risk. Both are taken as daily shots under the skin, though Victoza’s dose may be adjusted over time. The key difference is their active ingredients: Byetta uses exenatide, while Victoza uses liraglutide.

AI summary of the sources below.

Byetta Victoza
Active ingredientexenatideliraglutide
Manufacturerastrazenecanovo-nordisk
Routesubcutaneous injectionsubcutaneous injection
FDA-approved fortype 2 diabetestype 2 diabetes, cardiovascular risk reduction
Label updated2025-09-022023-02-06

Compare full details on the Byetta and Victoza pages.